US Patent:
20130096067, Apr 18, 2013
Inventors:
Norbert Perrimon - Arlington MA, US
Michele Markstein - Amherst MA, US
International Classification:
A01K 67/033
US Classification:
514 201, 800 13, 800 3, 435 8
Abstract:
The present invention provides a transgenic tumor stem cell model and uses thereof. Also provided is a method to selectively inhibit cancer stem cells in a mammal having refractory intestinal cancer or a relapse of intestinal cancer.